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Sporotrichosis is a subacute or chronic dis-
ease that affects animals and humans caused 
by the dimorphic fungus Sporothrix schen-
kii.1 An epidemic of sporotrichosis has been 
noticed in the city of Rio de Janeiro from 
1998 onwards and having the cat as the 
main link in the epidemiological chain.2 We 
have missed a large proportion of these pa-
tients and adjuvant cryosurgery with liquid 
nitrogen3,4 has been performed in patients 
that persisted with one or two active lesions 
whereas the other healed after 2-3 months 
of treatment. This study aims at evaluat-
ing the role of adjuvant treatment in these 
patients. Methods: 9 patients (7 women/2 
men, mean age 45.8 years-old) with cuta-
neous-lymphatic and fixed sporotrichosis 
were selected (Figures 1 and 2). All patients 
Figure 1: Sporotrichosis: pre-treatment.
Figure 2: Sporotrichosis: before cryosurgery.
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Figure 3: Dimorphic fungus Sporothrix schenckii. (A): mycelium form (250C); (B): yeast form (370C).
had isolated Sporothrix schenckii in culture (Figure 3). 
Results: Patients underwent monthly sessions of cryosur-
gery with liquid nitrogen with two cycles of 15 seconds 
and halo of 5 mm (Figures 4 and 5) with an average of 
2.2 sessions (range 1-4 sessions). Five patients had exclu-
sive use of itraconazole for a mean period of 28.8 weeks 
(range 4-56 weeks) and after the introduction of adjuvant 
therapy were discharged after a mean period of 12 weeks 
(range 4-36 weeks). The patient who made use of potassi-
um iodide was discharged after two adjuvant therapy ses-
sions, totaling 12 weeks of treatment. The three patients 
who used itraconazole and terbinafine, itraconazole used 
primarily by an average of 21.2 weeks and due to lack of 
response initiated terbinafine, which when combined with 
adjuvant therapy were discharged after a mean period of 16 
weeks (range 4-28 weeks). In conclusion, cryosurgery with 
liquid nitrogen4 used in patients with slower response to 
systemic antifungal agents in a few sessions reduces treat-
ment time and thus reducing cost and side effects.
[Braz J Infect Dis 2011;15(2):181-183]©Elsevier Editora Ltda.
Figure 4: Technique of cryosurgery with liquid nitrogen and halo.
Figure 5: Sporotrichosis: post-treatment.
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